A simple education tool for ventricular assist device patients and their caregivers

Journal of Cardiovascular Nursing

Volumn 30, Issue 3, 2015, Pages E1-E10

  Barber, Julie ^a   Leslie, Gavin ^a,b  

^a CURTIN UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

aftercare; heart assist devices; heart failure; patient education

Indexed keywords

ADULT; AGED; CAREGIVER; FEEDBACK SYSTEM; FEMALE; HEART ASSIST DEVICE; HUMAN; MALE; MIDDLE AGED; PATIENT EDUCATION; PROSTHESIS-RELATED INFECTIONS; PUBLICATION; QUESTIONNAIRE; READING;

ADULT; AGED; CAREGIVERS; FEEDBACK; FEMALE; HEART-ASSIST DEVICES; HUMANS; LITERACY; MALE; MIDDLE AGED; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PROSTHESIS-RELATED INFECTIONS; SURVEYS AND QUESTIONNAIRES;

EID: 84928581535     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0000000000000122     Document Type: Article

References (55)

1. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J. 1998;19(suppl P):P9.
2. Mosterd A, HoesW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137-1146.
3. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statisticsY2010 update: A report fromthe American Heart Association. Circulation. 2010;121:e46Ye215.
4. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS Profiles of Advanced Heart Failure: The current picture. J Heart Lung Transplant. 2009;28(6):535-541.
5. National Heart Foundation of Australia and the Cardiac Society of Australia andNew Zealand (ChronicHeart Failure Guidelines ExpertWriting Panel). Guidelines for the Prevention, Detection and Management of Chronic Heart Failure in Australia. Canberra, Australia: National Heart Foundation of Australia; 2011.
6. Roger VW,Weston SA, RedfieldMM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292(3):344-350.
7. Pamboukian SV, Tallaj JA, Brown RN, et al. Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the SeattleHeart Failure Model. ASAIO J. 2012;58(2):93-97. doi: 10.1097/MAT.1090b1013e31824450f31824459.
8. Hershberger R,NaumanD,Walker T, DuttonD, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 2003;9(3):180-187.
9. Bentz B,Hupcey J, Polomano R, Boehmer J. A retrospective study of left ventricular assist device-related infections. J Cardiovasc Manag. 2004;15(1):9-16.
10. Barnes K. Complications in patients with ventricular assist devices. Dimens Crit Care Nurs. 2008;27(6):233-241.
11. Wilson S, Givertz M, Stewart G, Mudge G Jr. Ventricular assist devices: The challenges of outpatient management. Am J Cardiol. 2009;54(18):1647-1659.
12. Givertz MM. Ventricular assist devices. Circulation. 2011; 124(12):e305Ye311.
13. SlaughterMS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4): S1YS39.
14. Rose E, Gelijns A, Moskowitz A, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-1443.
15. StahovichM, Chillcott S, DembitskyW. The next treatment option: using ventricular assist devices for heart failure. Crit Care Nurs Q. 2007;30(4):337-346.
16. Rose E, Moskowitz A, Packer M, et al. The REMATCH trial: rationale, design, and end points. Ann Thorac Surg. 1999;67(3):723-730.
17. Holman W, Pamboukian S, Blood M, Tallaj J, McGiffin D, Kirklin J.Managing device infections: Are we progressing or is infection an insurmountable obstacle? ASAIO J. 2005; 51(4):452-455.
18. Kirklin J, Naftel D, Kormos R, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29(1):1-10.
19. Uslan D. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis. 2006;19(4):345.
20. Kamdar J, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge to transplant therapy. Ann Thorac Surg. 2008;86: 1227-1234.
21. Zierer A, Melby S, Voeller R, et al. Late-onset driveline infections: The Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84(2):515-520.
22. Allen J, Weiss E, Schaffer J, et al. Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant. 2010;29(3):278-285.
23. Bomholt T,Moser C, Sander K, et al. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome. Scand Cardiovasc J. 2011;45(5):273-278.
24. Gordon R, Quagliarello B, Lowy F. Ventricular assist devicerelated infections. Lancet Infect Dis. 2006;6(7):426-437.
25. Pereda D, Conte J. Left ventricular assist device driveline infections. Cardiol Clin. 2011;29(4):515-527.
26. KnowlesM. Modern Practice of Adult Education. Chicago, IL: Follett Publishing; 1970.
27. Andrus S, Dubois J, Jansen C, Kuttner V, Lansberry N, Lukowski L. Teaching documentation tool: building a successful discharge. Crit Care Nurse. 2003;23(2):39-48.
28. Moroney DA, Powers K. Outpatient use of left ventricular assist devices: nursing, technical, and educational considerations. Am J Crit Care. 1997;6(5):355-362.
29. Topkara V, Kondareddy S, Malik F, Wang I, Mann D, Ewald G. Infectious complications in patients with left ventricular assist device: etiology and outcome in the continuousflow era. Ann Thorac Surg. 2010;90:1270-1277.
30. Mano A, Fujita K, Uenomachi K, et al. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant. 2009;28(5):428-433.
31. DembitskyW, Tector A, Park S, et al. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg. 2004;78(6): 2123-2130.
32. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J. 2005;51(4):461-470. doi: 10.1097/01.mat.0000170620.65279.aa.
33. Pasque M, Hanselman T, Shelton K, et al. Surgical management of Novacor drive-line exit site infections. Ann Thorac Surg. 2002;74(4):1267-1268.
34. Corish C, Kennedy N. Protein-energy undernutrition in hospital in-patients. Br J Nutr. 2000;83:575-591.
35. Ng M. CachexiaVan intrinsic factor in wound healing. Int Wound J. 2010;7(2):107-113.
36. Stechmiller J. Understanding the role of nutrition and wound healing. Nutr Clin Pract. 2010;25(1):61-68.
37. National Health and Medical Research Council. Dietary Guidelines for Australians: A Guide to Healthy Eating. Canberra, Australia: Commonwealth of Australia; 2005.
38. Pratt R, Pellowe C,Wilson J, et al. EPIC2: national evidencebased guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65: S1YS59.
39. National Health and Medical Research Council. Australian Guidelines for the Prevention andControl of Infection inHealthcare. Canberra, Australia:Commonwealth of Australia; 2006.
40. HolmanW, Rayburn B,McGiffin D, et al. Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg. 2003;75(suppl 6):S48YS57. doi: 10.1016/s0003-4975 (03)00479-x.
41. Raymond A, Kfoury AG, Bishop C, et al. Obesity and left ventricular assist device driveline exit site infection. ASAIO J. 2010;56(1):57-60. doi: 10.1097/MAT.1090b1013e3181c 1879b1091.
42. Holdy K, Dembitsky W, Eaton L. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant. 2005;24(10):1690-1695.
43. Flesch R. A new readability yardstick. J Appl Psychol. 1948; 32:221-233.
44. Kincaid J, Fishburne R, Rogers R, Chissom B. Derivation of New Readability Formulas (Automated Readability Index, FogCount and FleschReading Ease Formula) for Navy Enlisted Personnel. Memphis, TN: US Naval Air Station; 1975.
45. Gunning R. The Technique of Clear Writing. New York, NY: McGraw-Hill International Book Co; 1952.
46. Senter R, Smith E. Automated Readability Index. Cincinnati, Ohio: University of Cincinnati; 1967.
47. McLaughlin G. SMOG GradingVa new readability formula. J Reading. 1969;12(8):639-646.
48. Hussey L. Strategies for effective patient education material design. J Cardiovasc Nurs. 1997;11(2):37-46.
49. Western Australian Department of Health. Style Guide for Corporate Visual Identity. Western Australian Department of Health, ed. Perth, Australia: Government of Western Australia; 2011.
50. Australian Commission on Safety and Quality in Health Care. National Safety and Quality Health Service Standards. Sydney, Australia: Australian Commission on Safety and Quality in Health Care; 2011.
51. SurveyMonkey.com LLC. 2012. http//www.survey monkey.com. Accessed September 13, 2012.
52. Strö mberg A, Ma rtensson J, Fridlund B, Levin L-A , Karlsson J-E, Dahlström U. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure. Results from a prospective, randomised study. Eur Heart J. 2003;24:1014-1023.
53. Warren E. Improving patient adherence. Pract Nurse. 2009; 38(7):33-35.
54. Kennedy AP, Rogers AE. Improving patient involvement in chronic disease management: The views of patients, GPs and specialists on a guide book for ulcerative colitis. Patient Educ Couns. 2002;47:257-263.
55. Grime J, Pollock K. Information versus experience: A comparison of an information leaflet on antidepressants with lay experience of treatment. Patient Educ Couns. 2004;54:361-368.